Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

India Medicated Confectionery Market

ID: MRFR/FnB/46076-HCR
200 Pages
Snehal Singh
Last Updated: April 06, 2026

India Medicated Confectionery Market Size, Share, Industry Trend & Analysis Research Report: By Application (Nutritional Supplements, Cough Drops, Pain Relief, Digestive Health, Cold Relief), By Formulation (Hard Candy, Chewy Candy, Gummies, Lozenges, Chocolate), By Distribution Channel (Supermarkets, Pharmacies, Online Retail, Health Food Stores, Convenience Stores) andBy End User (Children, Adults, Elderly)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

India Medicated Confectionery Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Food, Beverages & Nutrition, BY Application (USD Million)
  49.     4.1.1 Nutritional Supplements
  50.     4.1.2 Cough Drops
  51.     4.1.3 Pain Relief
  52.     4.1.4 Digestive Health
  53.     4.1.5 Cold Relief
  54.   4.2 Food, Beverages & Nutrition, BY Formulation (USD Million)
  55.     4.2.1 Hard Candy
  56.     4.2.2 Chewy Candy
  57.     4.2.3 Gummies
  58.     4.2.4 Lozenges
  59.     4.2.5 Chocolate
  60.   4.3 Food, Beverages & Nutrition, BY Distribution Channel (USD Million)
  61.     4.3.1 Supermarkets
  62.     4.3.2 Pharmacies
  63.     4.3.3 Online Retail
  64.     4.3.4 Health Food Stores
  65.     4.3.5 Convenience Stores
  66.   4.4 Food, Beverages & Nutrition, BY End User (USD Million)
  67.     4.4.1 Children
  68.     4.4.2 Adults
  69.     4.4.3 Elderly
  70. 5 SECTION V: COMPETITIVE ANALYSIS
  71.   5.1 Competitive Landscape
  72.     5.1.1 Overview
  73.     5.1.2 Competitive Analysis
  74.     5.1.3 Market share Analysis
  75.     5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  76.     5.1.5 Competitive Benchmarking
  77.     5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  78.     5.1.7 Key developments and growth strategies
  79.       5.1.7.1 New Product Launch/Service Deployment
  80.       5.1.7.2 Merger & Acquisitions
  81.       5.1.7.3 Joint Ventures
  82.     5.1.8 Major Players Financial Matrix
  83.       5.1.8.1 Sales and Operating Income
  84.       5.1.8.2 Major Players R&D Expenditure. 2023
  85.   5.2 Company Profiles
  86.     5.2.1 Pfizer Inc (US)
  87.       5.2.1.1 Financial Overview
  88.       5.2.1.2 Products Offered
  89.       5.2.1.3 Key Developments
  90.       5.2.1.4 SWOT Analysis
  91.       5.2.1.5 Key Strategies
  92.     5.2.2 Reckitt Benckiser Group plc (GB)
  93.       5.2.2.1 Financial Overview
  94.       5.2.2.2 Products Offered
  95.       5.2.2.3 Key Developments
  96.       5.2.2.4 SWOT Analysis
  97.       5.2.2.5 Key Strategies
  98.     5.2.3 Bayer AG (DE)
  99.       5.2.3.1 Financial Overview
  100.       5.2.3.2 Products Offered
  101.       5.2.3.3 Key Developments
  102.       5.2.3.4 SWOT Analysis
  103.       5.2.3.5 Key Strategies
  104.     5.2.4 Haleon plc (GB)
  105.       5.2.4.1 Financial Overview
  106.       5.2.4.2 Products Offered
  107.       5.2.4.3 Key Developments
  108.       5.2.4.4 SWOT Analysis
  109.       5.2.4.5 Key Strategies
  110.     5.2.5 Novartis AG (CH)
  111.       5.2.5.1 Financial Overview
  112.       5.2.5.2 Products Offered
  113.       5.2.5.3 Key Developments
  114.       5.2.5.4 SWOT Analysis
  115.       5.2.5.5 Key Strategies
  116.     5.2.6 GlaxoSmithKline plc (GB)
  117.       5.2.6.1 Financial Overview
  118.       5.2.6.2 Products Offered
  119.       5.2.6.3 Key Developments
  120.       5.2.6.4 SWOT Analysis
  121.       5.2.6.5 Key Strategies
  122.     5.2.7 Sanofi S.A. (FR)
  123.       5.2.7.1 Financial Overview
  124.       5.2.7.2 Products Offered
  125.       5.2.7.3 Key Developments
  126.       5.2.7.4 SWOT Analysis
  127.       5.2.7.5 Key Strategies
  128.     5.2.8 Church & Dwight Co., Inc. (US)
  129.       5.2.8.1 Financial Overview
  130.       5.2.8.2 Products Offered
  131.       5.2.8.3 Key Developments
  132.       5.2.8.4 SWOT Analysis
  133.       5.2.8.5 Key Strategies
  134.   5.3 Appendix
  135.     5.3.1 References
  136.     5.3.2 Related Reports
  137. 6 LIST OF FIGURES
  138.   6.1 MARKET SYNOPSIS
  139.   6.2 INDIA MARKET ANALYSIS BY APPLICATION
  140.   6.3 INDIA MARKET ANALYSIS BY FORMULATION
  141.   6.4 INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  142.   6.5 INDIA MARKET ANALYSIS BY END USER
  143.   6.6 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
  144.   6.7 RESEARCH PROCESS OF MRFR
  145.   6.8 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
  146.   6.9 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
  147.   6.10 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
  148.   6.11 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
  149.   6.12 FOOD, BEVERAGES & NUTRITION, BY APPLICATION, 2024 (% SHARE)
  150.   6.13 FOOD, BEVERAGES & NUTRITION, BY APPLICATION, 2024 TO 2035 (USD Million)
  151.   6.14 FOOD, BEVERAGES & NUTRITION, BY FORMULATION, 2024 (% SHARE)
  152.   6.15 FOOD, BEVERAGES & NUTRITION, BY FORMULATION, 2024 TO 2035 (USD Million)
  153.   6.16 FOOD, BEVERAGES & NUTRITION, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
  154.   6.17 FOOD, BEVERAGES & NUTRITION, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
  155.   6.18 FOOD, BEVERAGES & NUTRITION, BY END USER, 2024 (% SHARE)
  156.   6.19 FOOD, BEVERAGES & NUTRITION, BY END USER, 2024 TO 2035 (USD Million)
  157.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  158. 7 LIST OF TABLES
  159.   7.1 LIST OF ASSUMPTIONS
  160.     7.1.1
  161.   7.2 India MARKET SIZE ESTIMATES; FORECAST
  162.     7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  163.     7.2.2 BY FORMULATION, 2025-2035 (USD Million)
  164.     7.2.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
  165.     7.2.4 BY END USER, 2025-2035 (USD Million)
  166.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  167.     7.3.1
  168.   7.4 ACQUISITION/PARTNERSHIP
  169.     7.4.1

India Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Application (USD Million, 2025-2035)

  • Nutritional Supplements
  • Cough Drops
  • Pain Relief
  • Digestive Health
  • Cold Relief

Food, Beverages & Nutrition By Formulation (USD Million, 2025-2035)

  • Hard Candy
  • Chewy Candy
  • Gummies
  • Lozenges
  • Chocolate

Food, Beverages & Nutrition By Distribution Channel (USD Million, 2025-2035)

  • Supermarkets
  • Pharmacies
  • Online Retail
  • Health Food Stores
  • Convenience Stores

Food, Beverages & Nutrition By End User (USD Million, 2025-2035)

  • Children
  • Adults
  • Elderly

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions